Subchondral osteoclasts and osteoarthritis: new insights and potential therapeutic avenues

Osteoarthritis (OA) is the most common joint disease, and good therapeutic results are often difficult to obtain due to its complex pathogenesis and diverse causative factors. After decades of research and exploration of OA, it has been progressively found that subchondral bone is essential for its...

Full description

Bibliographic Details
Main Authors: Chen Wenlong, Wang Qiufei, Tao Huaqiang, Lu Lingfeng, Zhou Jing, Wang Qiang, Huang Wei, Yang Xing
Format: Article
Language:English
Published: China Science Publishing & Media Ltd. 2024-03-01
Series:Acta Biochimica et Biophysica Sinica
Subjects:
Online Access:https://www.sciengine.com/doi/10.3724/abbs.2024017
_version_ 1797208518212714496
author Chen Wenlong
Wang Qiufei
Tao Huaqiang
Lu Lingfeng
Zhou Jing
Wang Qiang
Huang Wei
Yang Xing
author_facet Chen Wenlong
Wang Qiufei
Tao Huaqiang
Lu Lingfeng
Zhou Jing
Wang Qiang
Huang Wei
Yang Xing
author_sort Chen Wenlong
collection DOAJ
description Osteoarthritis (OA) is the most common joint disease, and good therapeutic results are often difficult to obtain due to its complex pathogenesis and diverse causative factors. After decades of research and exploration of OA, it has been progressively found that subchondral bone is essential for its pathogenesis, and pathological changes in subchondral bone can be observed even before cartilage lesions develop. Osteoclasts, the main cells regulating bone resorption, play a crucial role in the pathogenesis of subchondral bone. Subchondral osteoclasts regulate the homeostasis of subchondral bone through the secretion of degradative enzymes, immunomodulation, and cell signaling pathways. In OA, osteoclasts are overactivated by autophagy, ncRNAs, and Rankl/Rank/OPG signaling pathways. Excessive bone resorption disrupts the balance of bone remodeling, leading to increased subchondral bone loss, decreased bone mineral density and consequent structural damage to articular cartilage and joint pain. With increased understanding of bone biology and targeted therapies, researchers have found that the activity and function of subchondral osteoclasts are affected by multiple pathways. In this review, we summarize the roles and mechanisms of subchondral osteoclasts in OA, enumerate the latest advances in subchondral osteoclast-targeted therapy for OA, and look forward to the future trends of subchondral osteoclast-targeted therapies in clinical applications to fill the gaps in the current knowledge of OA treatment and to develop new therapeutic strategies.
first_indexed 2024-04-24T09:40:05Z
format Article
id doaj.art-9b67050540414001a51b888c4bdd4af5
institution Directory Open Access Journal
issn 1672-9145
language English
last_indexed 2024-04-24T09:40:05Z
publishDate 2024-03-01
publisher China Science Publishing & Media Ltd.
record_format Article
series Acta Biochimica et Biophysica Sinica
spelling doaj.art-9b67050540414001a51b888c4bdd4af52024-04-15T07:14:57ZengChina Science Publishing & Media Ltd.Acta Biochimica et Biophysica Sinica1672-91452024-03-015649951210.3724/abbs.202401720d259ccSubchondral osteoclasts and osteoarthritis: new insights and potential therapeutic avenuesChen Wenlong0Wang Qiufei1Tao Huaqiang2Lu Lingfeng3Zhou Jing4Wang Qiang5Huang Wei6Yang Xing7["Orthopedics and Sports Medicine Center, Suzhou Municipal Hospital, Nanjing Medical University Affiliated Suzhou Hospital, Suzhou 215000, China","Gusu School, Nanjing Medical University, Suzhou 215000, China"]["Department of Orthopedics, the First Affiliated Hospital of Soochow University, Suzhou 215000, China"]["Department of Orthopedics, the First Affiliated Hospital of Soochow University, Suzhou 215000, China"]["Orthopedics and Sports Medicine Center, Suzhou Municipal Hospital, Nanjing Medical University Affiliated Suzhou Hospital, Suzhou 215000, China","Gusu School, Nanjing Medical University, Suzhou 215000, China"]["Orthopedics and Sports Medicine Center, Suzhou Municipal Hospital, Nanjing Medical University Affiliated Suzhou Hospital, Suzhou 215000, China","Gusu School, Nanjing Medical University, Suzhou 215000, China"]["Department of Orthopedics, the First Affiliated Hospital of Soochow University, Suzhou 215000, China"]["Department of Orthopaedics, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230026, China"]["Orthopedics and Sports Medicine Center, Suzhou Municipal Hospital, Nanjing Medical University Affiliated Suzhou Hospital, Suzhou 215000, China","Gusu School, Nanjing Medical University, Suzhou 215000, China"]Osteoarthritis (OA) is the most common joint disease, and good therapeutic results are often difficult to obtain due to its complex pathogenesis and diverse causative factors. After decades of research and exploration of OA, it has been progressively found that subchondral bone is essential for its pathogenesis, and pathological changes in subchondral bone can be observed even before cartilage lesions develop. Osteoclasts, the main cells regulating bone resorption, play a crucial role in the pathogenesis of subchondral bone. Subchondral osteoclasts regulate the homeostasis of subchondral bone through the secretion of degradative enzymes, immunomodulation, and cell signaling pathways. In OA, osteoclasts are overactivated by autophagy, ncRNAs, and Rankl/Rank/OPG signaling pathways. Excessive bone resorption disrupts the balance of bone remodeling, leading to increased subchondral bone loss, decreased bone mineral density and consequent structural damage to articular cartilage and joint pain. With increased understanding of bone biology and targeted therapies, researchers have found that the activity and function of subchondral osteoclasts are affected by multiple pathways. In this review, we summarize the roles and mechanisms of subchondral osteoclasts in OA, enumerate the latest advances in subchondral osteoclast-targeted therapy for OA, and look forward to the future trends of subchondral osteoclast-targeted therapies in clinical applications to fill the gaps in the current knowledge of OA treatment and to develop new therapeutic strategies.https://www.sciengine.com/doi/10.3724/abbs.2024017osteoarthritisosteoclastsubchondral bone
spellingShingle Chen Wenlong
Wang Qiufei
Tao Huaqiang
Lu Lingfeng
Zhou Jing
Wang Qiang
Huang Wei
Yang Xing
Subchondral osteoclasts and osteoarthritis: new insights and potential therapeutic avenues
Acta Biochimica et Biophysica Sinica
osteoarthritis
osteoclast
subchondral bone
title Subchondral osteoclasts and osteoarthritis: new insights and potential therapeutic avenues
title_full Subchondral osteoclasts and osteoarthritis: new insights and potential therapeutic avenues
title_fullStr Subchondral osteoclasts and osteoarthritis: new insights and potential therapeutic avenues
title_full_unstemmed Subchondral osteoclasts and osteoarthritis: new insights and potential therapeutic avenues
title_short Subchondral osteoclasts and osteoarthritis: new insights and potential therapeutic avenues
title_sort subchondral osteoclasts and osteoarthritis new insights and potential therapeutic avenues
topic osteoarthritis
osteoclast
subchondral bone
url https://www.sciengine.com/doi/10.3724/abbs.2024017
work_keys_str_mv AT chenwenlong subchondralosteoclastsandosteoarthritisnewinsightsandpotentialtherapeuticavenues
AT wangqiufei subchondralosteoclastsandosteoarthritisnewinsightsandpotentialtherapeuticavenues
AT taohuaqiang subchondralosteoclastsandosteoarthritisnewinsightsandpotentialtherapeuticavenues
AT lulingfeng subchondralosteoclastsandosteoarthritisnewinsightsandpotentialtherapeuticavenues
AT zhoujing subchondralosteoclastsandosteoarthritisnewinsightsandpotentialtherapeuticavenues
AT wangqiang subchondralosteoclastsandosteoarthritisnewinsightsandpotentialtherapeuticavenues
AT huangwei subchondralosteoclastsandosteoarthritisnewinsightsandpotentialtherapeuticavenues
AT yangxing subchondralosteoclastsandosteoarthritisnewinsightsandpotentialtherapeuticavenues